myeloproliferative disorder clonal evolution clonal evolution & stepwise progression to fibrosis,...
Post on 20-Jan-2018
226 Views
Preview:
DESCRIPTION
3 CML. Historical vs. Modern Perspective ParameterHistoricalModern CourseFatalIndolent PrognosisPoorExcellent 7-yr survival40%90% Frontline Rx Allogeneic SCT; IFN- Imatinib Second line Rx? New Tyrosine Kinase Inhibitors; allo SCT
top related